Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

Class II drug recalls - moderate risk

Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.

14,535 recalls, newest first.

Class II · Moderate risk

Tri-Lo-Sprintec

Failed Dissolution Specifications

Terminated Dissolution failure Teva Pharmaceuticals USA, Inc NDC 0093-2140-62 D-0428-2024
Class II · Moderate risk

Febuxostat Tablets 80mg

CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Ongoing Microbial contamination Sun Pharmaceutical Industries INC NDC 16714-060-01 D-0369-2024
Class II · Moderate risk

Febuxostat Tablets 40mg

CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Ongoing Microbial contamination Sun Pharmaceutical Industries INC NDC 16714-059-01 D-0368-2024
Class II · Moderate risk

S.P Labs

Failed Stability Specifications

Completed Stability / shelf life Specialty Process Labs LLC D-0447-2024
Class II · Moderate risk

S.P.Labs

Failed Stability Specifications

Completed Stability / shelf life Specialty Process Labs LLC NDC 81305-500-01 D-0446-2024
Class II · Moderate risk

FentaNYL citrate

Lack of Assurance of Sterility: Firm did not perform process validation.

Ongoing Sterility / contamination SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0436-2024
Class II · Moderate risk

Phenylephrine HCl

Lack of Assurance of Sterility: Firm did not perform process validation.

Ongoing Sterility / contamination SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0435-2024

Recalls by year